Faculty of Medicine, Kafrelsheikh University, Kafr El-Sheikh, Egypt.
Department of Medical Parasitology, Faculty of Medicine, KafrElsheikh University, Kafr El-Shaikh, Egypt.
BMC Public Health. 2023 Jan 27;23(1):180. doi: 10.1186/s12889-023-15025-y.
The novel coronavirus pandemic (COVID-19) has begun with a wave of misinformation and fear of infection. This may have led people to self-medicate inappropriately. The World Health Organization describes self-medication (SM) as utilizing medicines to relieve symptoms or health conditions without consulting a physician. Inappropriate drug use is a burden on both health resources and patient health in the Arab region. This study aimed to detect the prevalence and influencing factors of self-medication among the general Arab population during the COVID-19 pandemic.
A multinational cross-sectional study was conducted among the general population of ten Arab countries from early August to late October 2021. Participants aged 18 years or older could join the study via social media platforms. A convenience sampling technique was used. A developed and validated web-based questionnaire was used to collect data on self-medication practice, associated influencing factors, information sources, commonly used medications, and commonly treated conditions. Descriptive, univariate, and multivariate regression analyses were applied using IBM SPSS v 26 and R v 4.0.0 software.
A total of 8163 participants completed the questionnaire, and 518 participants were excluded from the analysis due to inconsistencies in their data. Almost two-thirds (62.7%) of participants reported practicing self-medication during the COVID-19 pandemic. At the country level, Egypt had the highest prevalence of self-medication practice (72.1%), while Palestine had the lowest prevalence (40.4%). The most commonly used drugs were analgesics, antipyretics, and vitamins (86, 65.1, and 57.1%, respectively), while antitussives and antibiotics scored 47.6 and 43.3%, respectively. Experience with similar health conditions (74.6%) and urgency of the problem (47.2%) were the most frequent factors that led to self-medication. Additionally, 38.2% of the self-medicated participants (SMPs) used drugs as prophylaxis against COVID-19. Pharmacist consultation was the most common source of information about self-medication (66.7%). Multivariate analysis showed that predictors of self-medication were older age (p = 0.008), presence of chronic illness (p = 0.015), and having monthly income or medical insurance that does not cover the treatment cost (p = 0.001, p < 0.001, respectively).
Self-medication is considered a common practice across the Arab population. It is necessary to regulate policies and raise awareness among the public about self-medication.
新型冠状病毒疫情(COVID-19)爆发初期,充斥着大量错误信息和对感染的恐惧,这可能导致人们不合理地自我用药。世界卫生组织将自我用药(SM)定义为在未经医生咨询的情况下使用药物来缓解症状或健康状况。在阿拉伯地区,不适当的药物使用不仅给卫生资源带来负担,也影响患者的健康。本研究旨在检测 COVID-19 大流行期间阿拉伯普通人群自我用药的流行率及其影响因素。
本研究为多国横断面研究,于 2021 年 8 月初至 10 月底在 10 个阿拉伯国家的普通人群中开展。年龄在 18 岁及以上的参与者可通过社交媒体平台参与本研究。采用便利抽样技术。使用自行开发并验证的基于网络的问卷收集自我用药实践、相关影响因素、信息来源、常用药物和常见治疗疾病的数据。使用 IBM SPSS v 26 和 R v 4.0.0 软件进行描述性、单变量和多变量回归分析。
共有 8163 名参与者完成了问卷,由于数据不一致,518 名参与者被排除在分析之外。近三分之二(62.7%)的参与者报告在 COVID-19 大流行期间进行了自我用药。从国家层面来看,埃及的自我用药比例最高(72.1%),而巴勒斯坦最低(40.4%)。最常用的药物是镇痛药、解热药和维生素,分别占 86%、65.1%和 57.1%,而镇咳药和抗生素的使用率分别为 47.6%和 43.3%。有类似健康状况的经历(74.6%)和问题的紧迫性(47.2%)是导致自我用药最常见的因素。此外,38.2%的自我用药参与者(SMP)使用药物预防 COVID-19。药师咨询是自我用药信息最常见的来源(66.7%)。多变量分析显示,自我用药的预测因素为年龄较大(p=0.008)、患有慢性病(p=0.015)以及月收入或医疗保险不涵盖治疗费用(p=0.001,p<0.001)。
自我用药在阿拉伯人群中被普遍认为是一种常见做法。有必要规范政策,并提高公众对自我用药的认识。